Cafepharma Daily Premium (On-Demand) Archive for April, 2025

Click a link below to view the mailing archive as if it had been sent to you.

2025-04-30 12:15AstraZeneca’s Truqap fails in another Phase III trial and more...
2025-04-29 12:15Novartis posts better-than-expected first-quarter sales, raises full-year guidance and more...
2025-04-28 12:15Medtronic Files for FDA Submission for the Hugo Robotic System and more...
2025-04-25 12:15US pharma tariffs would raise US drug costs by $51 billion annually, report finds and more...
2025-04-25 00:15Sen. Cassidy calls for 340B reform, increased oversight of hospitals, contract pharmacies and more...
2025-04-24 12:15Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs and more...
2025-04-24 00:15Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity and more...
2025-04-23 12:15Biotech’s ‘nauseating roller coaster’ repels investors and more...
2025-04-23 00:15Bausch Health, after setting up 'poison pill' defense, reveals activist investor Carl Icahn's 34% interest and more...
2025-04-22 12:15Regeneron signs $3 billion deal with contract drugmaker to boost US manufacturing and more...
2025-04-22 00:15Novo says it’s submitted obesity pill for FDA approval and more...
2025-04-21 12:15Sanofi, Regeneron win FDA nod for Dupixent in chronic hives and more...
2025-04-18 00:15Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts and more...
2025-04-17 12:15Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s and more...
2025-04-17 00:15First meeting of CDC vaccine advisers under RFK Jr. is mostly 'business as usual' and more...
2025-04-16 12:15Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal and more...
2025-04-16 00:15Trump signs executive action to lower drug prices and more...
2025-04-15 12:15GSK in breach for misleading prescription information on Omjjara, industry body says and more...
2025-04-15 00:15Novo Nordisk warns consumers about counterfeit versions of Ozempic in US and more...
2025-04-14 12:15Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan and more...
2025-04-14 00:15Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win and more...
2025-04-11 12:15The 5 largest biopharma layoffs of Q1 2025 and more...
2025-04-11 00:15Merck granted Rob Davis a pay boost to $23.2M, inching CEO’s 2024 compensation closer to large pharma peers and more...
2025-04-10 12:15Threat to FDA user fees program could set US back 35 years and more...
2025-04-10 00:15Large drugmakers spent millions protecting their CEOs last year amid 'heightened risk environment' and more...
2025-04-09 12:15Trump says ‘major’ tariffs coming on pharmaceuticals and more...
2025-04-09 00:15US risks losing biotech edge to China, report warns and more...
2025-04-08 12:15HHS leaves door open to future Medicare coverage of obesity drugs and more...
2025-04-08 00:15Health secretary RFK Jr. endorses the MMR vaccine — stoking fury among his supporters and more...
2025-04-07 12:15Sarepta and Roche aim to resume paused Elevidys trials following patient death and more...
2025-04-07 00:15Drug Patent Reform’s Been Postponed Repeatedly, Is The 119th Congress Ready To Act? and more...
2025-04-04 12:15The top 10 pharma R&D budgets for 2024 and more...
2025-04-04 00:15GSK resolves patent lawsuit against Pfizer over RSV vaccines and more...
2025-04-03 12:15FDA misses approval deadline for Novavax’s COVID-19 vaccine and more...
2025-04-03 00:15'Patently illegal': NIH and HHS face new lawsuit over $1.1B in revoked research grants and more...
2025-04-02 12:15Novo Holdings nearly doubles earnings as Wegovy swells coffers and more...
2025-04-02 00:15Boston Scientific’s Farapulse Triumphs Over Medtronic’s Artic Front in Atrial Fibrillation Trial and more...
2025-04-01 12:15Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis and more...
2025-04-01 00:15Medtronic Breaks Out Strong TAVR Data at ACC and more...

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe